Add-on Acquisition • Life Science

Fulgent Acquires StrataDx

On December 22, 2025, Fulgent acquired life science company StrataDx

Acquisition Context

This is Fulgent’s 4th transaction in the Life Science sector.
This is Fulgent’s 5th transaction in the United States.
This is Fulgent’s 1st transaction in Massachusetts.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	December 22, 2025
Target	StrataDx
Sector	Life Science
Buyer(s)	Fulgent
Deal Type	Add-on Acquisition
Advisor(s)	EV Health Partners (Financial)

Target Company

StrataDx

Lexington, Massachusetts, United States

StrataDx is a diagnostic pathology laboratory that provides clinical and anatomic pathology services to healthcare providers, supporting diagnoses from skin, oral, and other tissue specimens. StrataDx Is based in Lexington, Massachusetts.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Fulgent

El Monte, California, United States

Category	Company
Founded	2011
Sector	Life Science
Employees	1,313
Revenue	283M USD (2024)

DESCRIPTION

Fulgent is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent was founded in 2011 and is based in El Monte, California.

Deal Context for Buyer	#
Overall	5 of 5
Sector: Life Science	4 of 4
Type: Add-on Acquisition	5 of 5
State: Massachusetts	1 of 1
Country: United States	5 of 5
Year: 2025	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2025-12-22	BakoDx Alpharetta, Georgia, United States BakoDx provides specialty laboratory testing services that offer a comprehensive testing menu, including complete anatomic pathology services, proprietary molecular genetic testing, and peripheral neuropathy immuno-histochemical testing. Bako is based in Alpharetta, Georgia.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2025-12-22

BakoDx

Alpharetta, Georgia, United States

BakoDx provides specialty laboratory testing services that offer a comprehensive testing menu, including complete anatomic pathology services, proprietary molecular genetic testing, and peripheral neuropathy immuno-histochemical testing. Bako is based in Alpharetta, Georgia.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Massachusetts M&A - United States M&A - 2025 M&A